BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter ended December 31, 2021, and provided an update on the Company’s clinical development ...

In 2021, global biopharma licensing, collaborations and joint venture transactions hit record heights, although merger and acquisition (M&A) activity was lower than the previous two years. Similar to ...

To reflect a non-cash charge to other expense (income), net for the changes in fair value of warrant liabilities.

A multi-institutional team, including a Lawrence Livermore National Laboratory (LLNL) contributor, has proposed a framework for digital twin models of cancer patients that researchers say would create ...

Physicians said it is in payers’ interest to use artificial intelligence to address social determinants of health, to cover tests, and to gather data. Doing so could let them stratify who needs ...

Community oncology leaders urge 340B overhaul so drug discounts follow vulnerable cancer patients, with audits, transparency, ...

SAN DIEGO, Oct. 4, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced new clinical and preclinical research will be presented at ...

Lugano, Switzerland, 26 November 2021 – The ESMO Immuno-Oncology Congress 2021, the European platform dedicated to the development and use of immunotherapies for cancer treatment, will be held as an ...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris:IPH; Nasdaq:IPHA) (“Innate” or the “Company”) today announced that data from the Phase 2 expansion cohort (‘cohort ...

Objectives Virtual health has the potential to improve access to supportive oncology and improve operational performance; ...

Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India We systematically reviewed ASCO ...